Contrasting Exactus (OTCMKTS:EXDI) & MariMed (OTC:MRMD)

Exactus (OTCMKTS:EXDI) and MariMed (OTC:MRMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership.

Insider & Institutional Ownership

0.1% of Exactus shares are owned by institutional investors. Comparatively, 0.2% of MariMed shares are owned by institutional investors. 65.0% of Exactus shares are owned by insiders. Comparatively, 19.0% of MariMed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Exactus and MariMed, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exactus	0	0	0	0	0.00
MariMed	0	0	0	1	4.00

Given Exactus’ higher probable upside, equities analysts plainly believe Exactus is more favorable than MariMed.

Profitability

This table compares Exactus and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Exactus	N/A	-3,272.69%	-185.29%
MariMed	-8.95%	1.58%	0.53%

Valuation & Earnings

This table compares Exactus and MariMed”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exactus	$2.07 million	0.00	-$9.46 million	N/A	N/A
MariMed	$148.60 million	0.19	-$16.03 million	($0.03)	-2.42

Exactus has higher earnings, but lower revenue than MariMed.

Volatility & Risk

Exactus has a beta of 4.21, suggesting that its share price is 321% more volatile than the S&P 500. Comparatively, MariMed has a beta of 2.99, suggesting that its share price is 199% more volatile than the S&P 500.

Summary

MariMed beats Exactus on 7 of the 12 factors compared between the two stocks.

About Exactus

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.